当前位置: X-MOL 学术J. Neuroendocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
Journal of Neuroendocrinology ( IF 3.2 ) Pub Date : 2023-10-05 , DOI: 10.1111/jne.13343
Beata Kos-Kudła 1 , Justo P Castaño 2 , Timm Denecke 3 , Enrique Grande 4 , Andreas Kjaer 5 , Anna Koumarianou 6 , Louis de Mestier 7 , Stefano Partelli 8 , Aurel Perren 9 , Stefan Stättner 10 , Juan W Valle 11, 12 , Nicola Fazio 13
Affiliation  

This ENETS guidance paper for well-differentiated nonfunctioning pancreatic neuroendocrine tumours (NF-Pan-NET) has been developed by a multidisciplinary working group, and provides up-to-date and practical advice on the management of these tumours. Using the extensive experience of centres treating patients with NF-Pan-NEN, the authors of this guidance paper discuss 10 troublesome questions in everyday clinical practice. Our many years of experience in this field are still being verified in the light of the results of new clinical, which set new ways of proceeding in NEN. The treatment of NF-Pan-NEN still requires a decision of a multidisciplinary team of specialists in the field of neuroendocrine neoplasms.

中文翻译:

欧洲神经内分泌肿瘤协会 (ENETS) 2023 年无功能性胰腺神经内分泌肿瘤指导文件

这份针对高分化非功能性胰腺神经内分泌肿瘤 (NF-Pan-NET) 的 ENETS 指导文件由多学科工作组编写,并提供了有关这些肿瘤治疗的最新实用建议。本指导文件的作者利用治疗 NF-Pan-NEN 患者的中心的丰富经验,讨论了日常临床实践中的 10 个棘手问题。我们在该领域多年的经验仍在根据新的临床结果得到验证,这为 NEN 的进展开辟了新的途径。NF-Pan-NEN的治疗仍需要神经内分泌肿瘤领域多学科专家团队的决定。
更新日期:2023-10-05
down
wechat
bug